Food Allergy Institute
Food Allergy Institute (FAI) is a nonprofit clinical and research center that treats children and adults with severe food allergies using its AI-powered Tolerance Induction Program (TIP), a 2.5–4 year personalized immunotherapy achieving 99% remission success across 13,000+ patients since 2015.
- Company typePrivate
- Founded2015
- HeadquartersLong Beach, United States
- Headcount101–250
- GTM typeB2C
- OfferingServices
What Food Allergy Institute does
Food Allergy Institute (FAI), founded in 2015 as a clinical division of the nonprofit TPIRC, operates a vertically integrated food-allergy treatment platform built around the Tolerance Induction Program (TIP). TIP is a 2.5–4 year, AI-driven immunotherapy that uses biosimilar proteins to safely prime the immune system before introducing real-food allergen doses, achieving a 99% success rate with under 1% adverse-event rate versus 20%+ for traditional exposure therapies. The personalization is powered by a proprietary machine-learning model — pioneered by founding engineer Herman Sandhu — that analyzes 300+ biomarkers per patient drawn from Aperture Immunodiagnostics, FAI's in-house CLIA and COLA Certified high-complexity laboratory, and outputs individualized dosing plans using 143 pharmaceutical-grade gummy products manufactured by FAI's in-house Food Laboratory.
FAI sells TIP primarily direct-to-consumer to families of children with severe food allergies, with adult segments (ages 26–50) and complex multi-allergen / comorbid cases (asthma, eczema, EoE, IBS, celiac) as secondary targets. Revenue is split between an all-inclusive cash-pay subscription ($979/month for ages 18 months–25; $1,079/month for adults) and an insurance-based membership ($440/month plus PPO billing through Aetna, Anthem Blue Cross, Cigna, Blue Shield, United Healthcare and others); year-one cash-pay costs are approximately $11,748 with onboarding, launch and food-challenge fees on top. More than 51% of patients travel from outside California, drawn by patient-referral incentives, provider outreach, earned media, and an active community mentorship program.
The organization is scaling physically from two Southern California clinics (Long Beach Willow Clinic and Vista) into new geographies, with an East Bay (Fremont) clinic opening in July 2025 and a Tri-State Area clinic planned for Fall 2026. Operational leadership — drawn from Amgen, Bank of America, Advantage Solutions, Chipotle, and Medtronic — is being layered onto founder Dr. Inderpal Randhawa's clinical and protocol creation role as the institute executes a multi-state build-out funded by patient-subscription revenue rather than external capital.
Food Allergy Institute firmographics
Firmographics- Name
- Food Allergy Institute
- Legal name
- Food Allergy Institute™
- Website
- https://foodallergyinstitute.com
- Company type
- Private
- Founded year
- 2015
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- Food Allergy Institute (FAI) is a nonprofit clinical and research center that treats children and adults with severe food allergies using its AI-powered Tolerance Induction Program (TIP), a 2.5–4 year personalized immunotherapy achieving 99% remission success across 13,000+ patients since 2015.
- Ownership category
- akta.pro rank
Food Allergy Institute industry classification
Industry- Product category
- Food Allergy Treatment Services
- NAICS
- Dairy Product Manufacturing (3115)
- SIC
- Food And Kindred Products (2000)
- akta.pro primary industry
- Food Allergy Evaluation & Management (HLAKAAAD)
- akta.pro secondary industry
- Allergen Presence & Cross-Contact Verification (ELISA/PCR; allergen cleaning validation) (AFALAHAB)
Keywords
Where Food Allergy Institute is headquartered
LocationHeadquarters
- HQ city
- Long Beach
- HQ country
- United States
- HQ region
- North America
Offices5 records
Markets served
Food Allergy Institute business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- TIP Subscription Plan (Cash Pay): All-inclusive monthly subscription covering tolerance induction program fee, annual diagnostic testing, and clinical office visits. Primary revenue stream for self-pay and international patients. HSA/FSA eligible.
- TIP Membership with Insurance: Monthly membership fee ($440/month) plus insurance billing for clinical services. In-network with most major PPOs. Clinical visits, food challenges, and lab work billed to insurance. TIP Fee remains out-of-pocket.
- Clinical Services Fees: Per-visit fees for food challenges ($435/visit), onboarding visits ($3,900), launch visits ($1,460), and annual remission visits. Billed separately from subscription or included in cash bundle.
- SLIT (Sublingual Immunotherapy): Environmental allergy treatment for patients requiring it. Billed quarterly ($300-$350/quarter). Not covered by insurance.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Monthly | TIP Subscription Plan for ages 18 months - 25 years |
| Subscription | Monthly | TIP Subscription Plan for ages 26-50 years |
| Subscription | Monthly | TIP Membership with Insurance |
| Unit Pricing | Pay-as-you-go | Year 1 Onboarding Visit (Zone 1) |
| Unit Pricing | Pay-as-you-go | Launch Visit (Zone 1) |
| Unit Pricing | Pay-as-you-go | Food Challenge Visits (Zone 1) |
| Subscription | Monthly | SLIT (Sublingual Immunotherapy) |
| Hybrid | Monthly | Insurance-covered PPO Plans |
Go-to-market motion3 records
Distribution channels5 records
Marketing channels13 records
Food Allergy Institute product offering
Product offeringCore offering
Food Allergy Institute provides AI-powered, personalized food allergy treatment through its Tolerance Induction Program (TIP), which uses machine learning analysis of patient biomarkers and biosimilar proteins to safely build tolerance to food allergens over a 2.5-4 year course, achieving remission rather than mere desensitization. Treatment is delivered through Southern California clinics, supplemented by pharmaceutical-grade gummy dosing products manufactured in-house and a CLIA-certified diagnostic laboratory for component-resolved testing.
Product overview
Food Allergy Institute operates as a unified food allergy treatment platform centered on the Tolerance Induction Program (TIP), an AI-powered personalized immunotherapy that analyzes 300+ biomarkers to create individualized treatment plans. The core offering combines the TIP program with proprietary pharmaceutical-grade gummy dosing products manufactured in-house, supported by the Aperture Immunodiagnostics CLIA-certified laboratory. Patients can access treatment through either the all-inclusive TIP Subscription Plan ($979-$1,079/month) or the TIP Membership with Insurance plan, with optional Sublingual Immunotherapy (SLIT) add-on for environmental allergies. The TIP Connect patient portal enables enrollment and ongoing program management.
Differentiator
Problem solved
Functional benefit
Brands
- TIP (Tolerance Induction Program): The core treatment program - a personalized, data-driven food allergy treatment using real foods to build tolerance through AI-powered protocols
- TIP Connect
- Food Freedom
Products and services
- Tolerance Induction Program (TIP) Personalized AI-driven food allergy treatment program for patients aged 18 months to 50 years that uses real natural foods and biosimilar proteins to build tolerance and achieve lasting food freedom.
- TIP Subscription Plan All-inclusive cash-pay monthly subscription covering TIP program fee, annual diagnostic testing, and clinical office visits at $979/month for ages 18 months-25 years and $1,079/month for ages 26-50 years. HSA/FSA eligible.
- TIP Membership with Insurance Insurance-based membership plan at $440/month with insurance billed for clinical services and diagnostic tests; available with major PPO carriers including Aetna, Cigna, Blue Shield, Anthem, United Healthcare, and others.
- TIP Gummy Doses Pharmaceutical-grade gummy doses containing precise milligram amounts of nuts, grains, seeds, or legumes for at-home dosing during TIP treatment; 143 unique formulations manufactured in-house by Food Laboratory Scientists.
- Aperture Immunodiagnostics CLIA and COLA certified high-complexity diagnostic laboratory performing component-resolved blood testing for 130+ allergens and hundreds of biomarkers, supporting TIP treatment planning and therapeutic monitoring.
- Sublingual Immunotherapy (SLIT) Environmental allergy treatment administered under the tongue for patients requiring management of cross-reacting environmental allergies during TIP, billed quarterly at $300-$350.
- TIP Connect Patient portal for TIP families to access enrollment forms, grant requests, FSA/HSA documentation, provider communications, and program management tools.
Quantifiable outcome
- 99% success rate for patients completing TIP program
- +5 more outcomes
Companies that use Food Allergy Institute
Customer profileSegments4 records
Ideal customer profiles3 records
Food Allergy Institute technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability4 records
Feature4 records
Food Allergy Institute partnerships and signals
Strategic signalPartnerships
Eleven partnerships are on record, tiered minor and core.
- Enterprise Rent-A-CarminorPartnership providing rental car discounts for traveling TIP families. Account #: XZ32748. Located at airports and local neighborhoods. Discounts vary based on booking time and availability.
- National Car RentalminorRental car partnership providing discounts for TIP families traveling to clinics. Discounts vary based on booking time and availability.
- Aperture ImmunodiagnosticscoreCLIA and COLA Certified high-complexness laboratory that is part of TPIRC ecosystem. Performs component-resolved diagnostic testing for 130+ allergen components essential for TIP treatment planning. Only diagnostic facility with complete test set for TIP protocols.
- TPIRC (Translational Pulmonary and Immunology Research Center)coreNon-profit parent organization of Food Allergy Institute. Focuses on development of cutting-edge treatment protocols for rare and orphan diseases using comprehensive diagnostic tools and patient-driven research. Houses TPIRC Biobank for biological samples and patient data supporting food anaphylaxis research.
- Hotel MayaminorPartner hotel in Long Beach offering corporate rates for TIP families. Address: 700 Queensway Dr., Long Beach, CA 90802. Corporate Code: P75.
- Hyatt Regency Long BeachminorPartner hotel in Long Beach with negotiated rates for TIP families traveling to clinics. Address: 200 South Pine Avenue, Long Beach CA 90802.
- Homewood Suites by Hilton Long Beach AirportminorPartner hotel with kitchen suites ideal for TIP families on extended treatment visits. Corporate Code: 3249070.
- Hyatt Place San Diego/Vista-CarlsbadminorPartner hotel near Vista clinic with negotiated rates. Address: 2645 South Melrose Dr., Vista CA 92081.
- Hyatt House CypressminorPartner hotel near Orange County clinic with shuttle transportation to clinic, complimentary parking, and World of Hyatt points. Address: 5905 Corporate Ave, Cypress, CA 90630.
- Southwest AirlinesminorSouthwest Companion Pass benefit referenced for TIP families - allows qualifying members to bring a companion fly free (excluding taxes and fees).
- Hyatt Place FremontminorPartner hotel near Fremont (East Bay) clinic location. Address: 3101 W Warren Ave, Fremont, CA 94538.
Scale indicators10 records
Recent moves8 records
Expansion highlights5 records
Food Allergy Institute competitors and assessment
Company assessmentEmerging players
- Intrommune Therapeutics: Clinical-stage company developing a novel oral mucosal immunotherapy (OMIT) platform for food and environmental allergies. Comparable to FAI as an alternative food allergy immunotherapy developer, though pursuing a more conventional pharma approval pathway.
- DBV Technologies: Developer of the Viaskin epicutaneous immunotherapy patch for peanut and other food allergies. Comparable as a food allergy immunotherapy modality competitor with a differentiated delivery mechanism (skin patch), though it has yet to achieve broad commercial scale.
- Alladapt Immunotherapeutics: Clinical-stage biopharmaceutical company developing ADP101, a single multi-food oral immunotherapy candidate designed to address multiple food allergies simultaneously. Directly comparable to FAI's multi-allergen treatment philosophy but pursuing an FDA-regulated pharmaceutical pathway.
Direct peers
- Mount Sinai Jaffe Food Allergy Institute: A major academic food allergy treatment and research center at the Icahn School of Medicine. Directly comparable to FAI as a specialty food allergy clinical program, though predominantly operating in an academic/research setting rather than a subscription-based clinical model.
- Boston Children's Hospital Food Allergy Program: Leading pediatric food allergy clinical and research program at a top academic medical center. Competes for the same severe pediatric food allergy patient population and conducts OIT and related immunotherapies within an academic framework.
- Cincinnati Children's Hospital - Food Allergy Center: One of the highest-volume pediatric food allergy treatment centers in the US, with active OIT and multi-food allergen programs. Directly comparable to FAI in clinical scope, with a similar emphasis on treating complex multi-allergen pediatric cases.
Broad incumbents
- Genentech (Roche) - Xolair: Maker of Xolair (omalizumab), which received FDA approval in 2024 to reduce allergic reactions to multiple foods. A broad pharmaceutical incumbent offering a biologic option for food allergy risk reduction that competes for the same patient pool as FAI's TIP.
- Aimmune Therapeutics (Nestlé Health Science): Developer of Palforzia, the first FDA-approved oral immunotherapy for peanut allergy (now part of Nestlé Health Science). Overlaps with FAI on food allergy OIT but focuses on a single FDA-approved biologic rather than FAI's broader, multi-allergen personalized protocol.
Others
- Ready, Set, Food!: Consumer health company focused on early allergen introduction products for infants to prevent food allergies. Adjacent to FAI's mission (reducing food allergy burden) but operates in prevention rather than treatment, with a direct-to-consumer product model rather than clinical care.
Regional players
- Stanford Alliance for Food Allergy Research (SAFAR): Academic research consortium at Stanford focused on food allergy pathogenesis, treatment, and prevention. Operates as a research-driven food allergy program in Northern California—adjacent to FAI's footprint—and overlaps in patient demographic and investigator focus.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights6 records
Customer concentration
Food Allergy Institute social profiles
Digital presenceFood Allergy Institute compliance and trust
Trust signalCompliance2 records
Food Allergy Institute financial estimates
Financial estimateRevenue estimate
Valuation estimate
Food Allergy Institute leadership team
Management profileNumber of profiles
Profiles10 records
Food Allergy Institute subsidiaries and ownership
Company hierarchySubsidiaries2 records
Food Allergy Institute funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Food Allergy Institute M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Food Allergy Institute
What does Food Allergy Institute do?
Food Allergy Institute provides AI-powered, personalized food allergy treatment through its Tolerance Induction Program (TIP), which uses machine learning analysis of patient biomarkers and biosimilar proteins to safely build tolerance to food allergens over a 2.5-4 year course, achieving remission rather than mere desensitization. Treatment is delivered through Southern California clinics, supplemented by pharmaceutical-grade gummy dosing products manufactured in-house and a CLIA-certified diagnostic laboratory for component-resolved testing.
Is Food Allergy Institute a public or private company?
Food Allergy Institute is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was Food Allergy Institute founded?
Food Allergy Institute was founded in 2015. It employs 101 to 250 people.
Where is Food Allergy Institute based?
Food Allergy Institute is headquartered in Long Beach, United States, in the North America region.
How does Food Allergy Institute make money?
Four revenue lines are on record. TIP Subscription Plan (Cash Pay) is the primary driver. The others are TIP Membership with Insurance, clinical Services Fees and SLIT (Sublingual Immunotherapy).
Who are Food Allergy Institute's main competitors?
Emerging players on record are Intrommune Therapeutics, DBV Technologies and Alladapt Immunotherapeutics. Direct peers are Mount Sinai Jaffe Food Allergy Institute, Boston Children's Hospital Food Allergy Program and Cincinnati Children's Hospital - Food Allergy Center. Broad incumbents are Genentech (Roche) - Xolair and Aimmune Therapeutics (Nestlé Health Science). Ready, Set, Food! is listed as an others. Stanford Alliance for Food Allergy Research (SAFAR) is listed as a regional player.
Does Food Allergy Institute have an API?
No public API is recorded for Food Allergy Institute.
What industry is Food Allergy Institute in?
Food Allergy Institute's product category is Food Allergy Treatment Services. Its primary akta.pro industry code is HLAKAAAD, Food Allergy Evaluation & Management, with a secondary code of AFALAHAB, Allergen Presence & Cross-Contact Verification (ELISA/PCR; allergen cleaning validation). Its NAICS code is 3115 and its SIC code is 2000.